Jump to content

Anat Cohen-Dayag

From Wikipedia, the free encyclopedia
Anat Cohen-Dayag
Nationality Israel
Alma materWeizmann Institute of Science
Ben-Gurion University
Scientific career
Fieldsbiochemist

Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli biotechnology firm Compugen Ltd, a company involved in drug discovery. She previously worked as a scientist at the R&D department of Orgenics.

Education

[edit]

She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science.[1][2][3]

References

[edit]
  1. ^ "Anat Cohen Dayag - Forbes". People.forbes.com. 2012-04-18. Archived from the original on 2011-06-11. Retrieved 2012-08-14.
  2. ^ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". FierceBiotech. Retrieved 2012-08-14.
  3. ^ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". www.fiercebiotech.com. Retrieved 2021-03-14.


pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy